Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Blood (2012) 120 (21): 4549.

https://doi.org/10.1182/blood.V120.21.4549.4549

Published: 2012

Journal Articles

Iron Overload in Patients with Hematological Disorders Undergoing Allogeneic HSCT: Unrevealed Implication in Different Outcomes

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Anne Cordonnier, Richard Cohen, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Colette Chapuis-Cellier, MD

Blood (2012) 120 (21): 4527.

https://doi.org/10.1182/blood.V120.21.4527.4527

Published: 2012

Journal Articles

High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Valerie Dubois, MD, Jean-Paul Bourgeot, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Valerie Mialou, Valérie Chapelle, Sothiny Sar, Olivier Hequet, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Yves Bertrand

Blood (2012) 120 (21): 1992.

https://doi.org/10.1182/blood.V120.21.1992.1992

Published: 2012

Journal Articles

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Valéerie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 604.

https://doi.org/10.1182/blood.V120.21.604.604

Published: 2012

Journal Articles

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm. M., Stéphane Morisset, Stat., Carine Champigneulle, CRA, Florence Ranchon, Marie Y. Detrait, MD, Hélène Labussière-Wallet, MD, Sophie Ducastelle, MD, Franck E. Nicolini, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, Caroline Le jeune, MD, Eric Wattel, MD, PhD, Catherine Rioufol, PharmD, Fiorenza Barraco, MD

Blood (2012) 120 (21): 5070.

https://doi.org/10.1182/blood.V120.21.5070.5070

Published: 2012

Journal Articles

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

Valérie Dubois, MD, Mohamad Sobh, Pharm.M., Stéphane Morisset, Stat., Hélène Labussière-Wallet, MD, Marie Y. Detrait, MD, Sylvie Rey, Isabelle Mollet, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Xavier Thomas, MD, Franck E. Nicolini, MD, PhD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 4180.

https://doi.org/10.1182/blood.V120.21.4180.4180

Published: 2012

Journal Articles

The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning Regimens

Marie Y. Detrait, MD, Valerie Dubois, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Nathalie Tedone, CRA, Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Lilia Gillis, MD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Mauricette Michallet

Blood (2011) 118 (21): 2038.

https://doi.org/10.1182/blood.V118.21.2038.2038

Published: 2011

Journal Articles

Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)

Marie Y. Detrait, MD, Patrice Chevallier, MD, PhD, Mohamad Sobh, Pharm.M., Thierry Guillaume, Xavier Thomas, MD, PhD, Stephane Morisset, Stat., Nathalie Tedone, CRA, Jacques Delaunay, MD, Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Mohamad Mohty, Mauricette Michallet

Blood (2011) 118 (21): 1957.

https://doi.org/10.1182/blood.V118.21.1957.1957

Published: 2011

Journal Articles

Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor Selection

Marie Y. Detrait, MD, Valerie Dubois, MD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Franck E. Nicolini, MD, PhD, Helene Labussiere, MD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Sophie Ducastelle, MD, Jihane Fattoum, MD, PhD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Nathalie Tedone, CRA, Sylvie Rey, Mauricette Michallet

Blood (2011) 118 (21): 4481.

https://doi.org/10.1182/blood.V118.21.4481.4481

Published: 2011

Journal Articles

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better Management,

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Jihane Fattoum, MD, PhD, Nathalie Tedone, CRA, Youcef Chelghoum, MD, Giovanna Cannas, MD, Xavier Thomas, MD, PhD, Franck E. Nicolini, MD, PhD

Blood (2011) 118 (21): 4093.

https://doi.org/10.1182/blood.V118.21.4093.4093

Published: 2011

Journal Articles

Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and Siblings

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Marie Y. Detrait, MD, Helene Labussiere, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Jihane Fattoum, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, PhD, Franck E. Nicolini, MD, PhD

Blood (2011) 118 (21): 3087.

https://doi.org/10.1182/blood.V118.21.3087.3087

Published: 2011

Journal Articles

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Helene Labussiere, MD, Marie Y. Detrait, MD, Franck E. Nicolini, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, PhD, Nathalie Tedone, CRA, Youcef Chelghoum, MD, Jihane Fattoum, MD, PhD, Isabelle Mollet, Valerie Dubois, MD

Blood (2011) 118 (21): 3111.

https://doi.org/10.1182/blood.V118.21.3111.3111

Published: 2011

Journal Articles

Serum Kappa/Lambda Ratio, An Independent Prognostic Factor at Diagnosis and Serum Free-Light Chains Level, An Early Indicator of Relapse/Progression In Multiple Myeloma

Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Taoufik Guilli, MSc, Sophie Ducastelle-Lepretre, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Giovanna Cannas, MD, Xavier Thomas, MD, PhD, Aline Praire, MSc, Helene Labussiere, MD, Franck E Nicolini, MD, PhD, Colette Chapuis-Celier, MD, Mauricette Michallet, MD, PhD

Blood (2010) 116 (21): 2954.

https://doi.org/10.1182/blood.V116.21.2954.2954

Published: 2010

Journal Articles

Erythropoietin Use In Patients with AML or Undergoing Allogeneic HSCT Significantly Improves Quality of Life and Reduces Red Blood Cells and Platelets Transfusions without Any Survival Effect.

Mauricette Michallet, Karine Goldet, CRA, Stephane Morisset, Stat., Mohamad Sobh, Pharm., M., Youcef Chelghoum, MD, Xavier Thomas, MD, PhD, Helene Labussiere, MD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Jean Vial, Catherine Renzullo, Pharm., Carole Paillet, Pharm., Christine Pivot, Pharm., Perrine Badol-Van Straaten, Angelique Denis, Anne Termoz, Franck E Nicolini, MD, PhD, Isabelle Jaisson-Hot

Blood (2010) 116 (21): 3810.

https://doi.org/10.1182/blood.V116.21.3810.3810

Published: 2010

Journal Articles

Faster Registration on International Donor Registries and Shorter Time to Allogeneic Hematopoietic Stem Cell Transplantation After Having Found a Donor Confers Better Outcome In Acute Leukemia Patients

Mauricette Michallet, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Helene Labussiere, MD, Franck E Nicolini, MD, PhD, Sophie Ducastelle, MD, Fiorenza Barraco, MD, Nathalie Tedone, CRA, Jihane Fatoum, MD, Marie Detrait, MD, Sylvie Rey, Valerie Dubois, MD

Blood (2010) 116 (21): 2371.

https://doi.org/10.1182/blood.V116.21.2371.2371

Published: 2010

Journal Articles

Invasive Aspergillosis: A New Important Risk Factor On Short and Long-Term Survival of AML Patients.

Blood (2009) 114 (22): 1010.

https://doi.org/10.1182/blood.V114.22.1010.1010

Published: 2009

Journal Articles

Allogeneic Hematopoietic Stem Transplantation Does Not Erase the Impact of the New Prognosis Classification in AML and the Negative Influence of Evi1 and Flt3 ITD Mutations.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Sandrine Hayette, MD, Carole Charlot, Mohamed El Hamri, PhD, Nathalie Tedone, Franck Emmanuel Nicolini, MD, PhD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Virelzier, MD, Sophie Ducastelle, MD, Fiorenza Baracco, MD, Isabelle Tigaud, MD, Xavier Thomas, MD, PhD

Blood (2009) 114 (22): 4678.

https://doi.org/10.1182/blood.V114.22.4678.4678

Published: 2009

Journal Articles

HLA Matching Is More Critical Than CMV Matching in Predicting Non-Relapse-Mortality of Patients Undergoing HSCT From An Unrelated Donor: A Retrospective Monocenter Study.

Roberto Crocchiolo, MD, Sophie Ducastelle, MD, Hélène Labussière, MD, Franck Emmanuel Nicolini, MD, PhD, Xavier Thomas, MD, PhD, Fiorenza Barraco, MD, Giovanna Cannas, MD, Samia Madene, MD, Youcef Chelghoum, MD, Nathalie Tedone, Mohamad Sobh, Pharm.M, Mauricette Michallet, MD, PhD

Blood (2009) 114 (22): 4336.

https://doi.org/10.1182/blood.V114.22.4336.4336

Published: 2009

Journal Articles

Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Stéphane Morisset, MSc, Giovanna Cannas, MD, Franck Emmanuel Nicolini, MD, PhD, Sophie Ducastelle, MD, Emmanuelle Nicolas-Virelizier, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Samira Kraghel, Nathalie Tedone, Mohamed El Hamri, PhD, Hélène Labussière, MD, Xavier Thomas, MD, PhD, Anne-Lise Bienvenu, Frédérique De Monbrison, Stéphane Picot, Marie-Christine Nicoll, Philippe Vanhems, MD

Blood (2009) 114 (22): 4124.

https://doi.org/10.1182/blood.V114.22.4124.4124

Published: 2009

Journal Articles

Need of Reconsideration of Mobilization Strategy in Autologous Stem Cell Transplantation for Multiple Myeloma: Results of the Positive Impact of High Number of CD34+ Infused Cells.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Benjamin Riche, PhD, Franck Emmanuel Nicolini, MD, PhD, Nicole Raus, Fiorenza Baracco, MD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Vierlizier, MD, Gilles Clapisson, Xavier Thomas, MD, Phd, Jacques Troncy, MD, Amina Zinai, DMD, MD, René Ecochard, PhD, Sophie Ducastelle, MD

Blood (2009) 114 (22): 3225.

https://doi.org/10.1182/blood.V114.22.3225.3225

Published: 2009

NARROW

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Iron Overload in Patients with Hematological Disorders Undergoing Allogeneic HSCT: Unrevealed Implication in Different Outcomes

High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies

A New Score to Determine the Probability of Finding an HLA Identical Unrelated Donor: A Validated Efficient Time and Cost Saving Method

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Cytokine Gene Polymorphisms and Severe Acute Graft-Versus-Host Disease (grade ≥II) After Allogeneic Hematopoietic Stem Cell Transplantation From HLA Identical Siblings

The Impact of Anti-HLA Antibodies on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes After Reduced-Intensity Conditioning Regimens

Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)

Highly Significant Impact of HLA-DRB3 and HLA-DRB4 Matching on Different Unrelated Allo-HSCT Outcomes: New Perspectives in the Unrelated Donor Selection

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better Management,

Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants From 10/10 HLA Unrelated Donors and Siblings

Double Cord Blood Units Allogeneic Transplantation for Hematological Malignancies: Study of the “3 Partners” Matching Variables on Transplant Outcomes

Serum Kappa/Lambda Ratio, An Independent Prognostic Factor at Diagnosis and Serum Free-Light Chains Level, An Early Indicator of Relapse/Progression In Multiple Myeloma

Erythropoietin Use In Patients with AML or Undergoing Allogeneic HSCT Significantly Improves Quality of Life and Reduces Red Blood Cells and Platelets Transfusions without Any Survival Effect.

Faster Registration on International Donor Registries and Shorter Time to Allogeneic Hematopoietic Stem Cell Transplantation After Having Found a Donor Confers Better Outcome In Acute Leukemia Patients

Invasive Aspergillosis: A New Important Risk Factor On Short and Long-Term Survival of AML Patients.

Allogeneic Hematopoietic Stem Transplantation Does Not Erase the Impact of the New Prognosis Classification in AML and the Negative Influence of Evi1 and Flt3 ITD Mutations.

HLA Matching Is More Critical Than CMV Matching in Predicting Non-Relapse-Mortality of Patients Undergoing HSCT From An Unrelated Donor: A Retrospective Monocenter Study.

Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival.

Need of Reconsideration of Mobilization Strategy in Autologous Stem Cell Transplantation for Multiple Myeloma: Results of the Positive Impact of High Number of CD34+ Infused Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only